Skip to content

The Effect of Bone Morphogenetic Protein (BMP) on Implant Stability and Bone Height in Immediately Loaded Implant Supported Mandibular Over denture

The Effect of Bone Morphogenetic Protein (BMP) on Implant Stability and Bone Height in Immediately Loaded Implant Supported Mandibular Over denture (Randomized Clinical Trial)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201312000640136
Enrollment
10
Registered
2013-09-07
Start date
2013-10-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases Oral Health Mandibular implant denture

Interventions

Conventional titanium dental implant coated with ready-made Bone morphogenetic protein (BMP
Conventional titanium dental implant

Sponsors

Faculty of Oral and Dental Medicine Cairo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Patient with completely edentulous upper and lower arch with normal maxillomandibular relationship (angle's class I ridge ) - Patient's age ranging from forty to sixty years old. - Patients should have be medically free. - The remaining residual ridge had enough height, width and free from any signs of ulceration or inflammation. - Patient should have adequate interarch distance >10mm. - Patient should be with good oral hygiene - Patients are non- smokers. - All patients had been edentulous from at least 1 year before implant placement

Exclusion criteria

Exclusion criteria: - Partially edentulous patient. - Patients with TMJ disorders, hemi-mandiblectomy or total maxilloectomy . - Patients administrated systemic drugs which may affect the bone healing or osseointegration around the dental implants. - Patients with any systemic disease that may interfere with dental implants placement and/or Osseo integration e.g. uncontrolled diabetes, hypertension, blood diseases, bone diseases, smoking. - uncooperative patients - Patients with inadequate arch size and width.

Design outcomes

Primary

MeasureTime frame
Osseointegration (Bone height) around the implant surface

Secondary

MeasureTime frame
Implant stability (frequency resonance analysis)

Countries

Egypt

Contacts

Public ContactAzza Farahat

Lecturer of Removable Prosthodontics faculty of oral and dental medicine .Cairo university

Azza_farahat56@yahoo.com00201276096893

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026